Able Laboratories, Inc.

FDA approves methamphetamine hydrochloride; company reports financials

Published in Healthcare Mergers, Acquisitions and Ventures Week, March 27th, 2004

Able Laboratories, Inc., (ABRX), reported quarterly financial results and that it has received U.S. Food & Drug Administration (FDA) approval for its Abbreviated New Drug Application (ANDA) for Methamphetamine Hydrochloride Tablets, USP 5 mg CII, which is therapeutically equivalent to Desoxyn Tablets, 5mg of Ovation Pharmaceuticals, Inc.

The total market for Able's newly approved drug (used in treatment for attention deficit disorder with hyperactivity and exogenous obesity) is estimated to be approximately $4 million according to recent market data.

Able is the first company to receive an ANDA approval for this product and will be the first company...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week

Source: Healthcare Mergers, Acquisitions and Ventures Week (2004-03-27)

More Articles from Healthcare Mergers, Acquisitions and Ventures Week

Abgenix, Inc.
Biotech company reports loss of $0.60 per share
Access Pharmaceuticals, Inc.
Pharmaceutical company completes $9.7M private placement
Adherex Technologies, Inc.
Cancer therapeutics company reports loss of $0.03 per share
Advanced Medical Optics, Inc.
Ophthalmic device firm reports 13.5% increase in revenue
Aequitas
New biopharmaceutical index published
AlgoRx Pharmaceuticals, Inc.
Pain drug developer raises $65M in series C financing
More from this issue of Healthcare Mergers, Acquisitions and Ventures Week

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry